Literature DB >> 23600380

Nanometric gold in cancer nanotechnology: current status and future prospect.

Mohammad Zaki Ahmad1, Sohail Akhter, Ziyaur Rahman, Shabib Akhter, Mohammed Anwar, Neha Mallik, Farhan Jalees Ahmad.   

Abstract

OBJECTIVES: This review elaborate on modified gold nanoparticulate concept in oncology, provides an overview of the use of gold nanoparticles in cancer treatment and discusses their potential applications and clinical benefits. KEY
FINDINGS: Modified gold nanoparticles (e.g. rod, multipod and star or a hollow structure such as shell, box and cage) have promising applications in the fields of drug delivery and photothermal therapy in oncology due to their unique optical and photothermal properties and their ability to modify the surface and conjugate drugs/molecules with gold nanomaterial. Modified gold nanoparticles exhibit strong light absorption in the near-infrared region in which light can penetrate deeply into soft tissue. Moreover, recent advances have opened the way to site-specific delivery by gold nanoparticle.
SUMMARY: Recent research and development in cancer-targeted gold nanovectors shows promise for maximizing the efficacy of anti-cancer drugs while decreasing their harmful systemic effects in chemotherapy. Moreover, gold nanoparticles can also serve as cancer therapeutic.
© 2012 The Authors. JPP © 2012. Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23600380     DOI: 10.1111/jphp.12017

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  19 in total

Review 1.  A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics.

Authors:  Shengping Qin; Brett Z Fite; M Karen J Gagnon; Jai W Seo; Fitz-Roy Curry; Frits Thorsen; Katherine W Ferrara
Journal:  Ann Biomed Eng       Date:  2013-09-10       Impact factor: 3.934

2.  Collision-induced dissociation of monolayer protected clusters Au144 and Au130 in an electrospray time-of-flight mass spectrometer.

Authors:  David M Black; Nabraj Bhattarai; Robert L Whetten; Stephan B H Bach
Journal:  J Phys Chem A       Date:  2014-10-31       Impact factor: 2.781

Review 3.  Hypusinated EIF5A as a feasible drug target for Advanced Medicinal Therapies in the treatment of pathogenic parasites and therapy-resistant tumors.

Authors:  Annette Kaiser; Enzo Agostinelli
Journal:  Amino Acids       Date:  2022-01-09       Impact factor: 3.520

4.  Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy.

Authors:  Jianliang Shen; Han-Cheon Kim; Chaofeng Mu; Emanuela Gentile; Junhua Mai; Joy Wolfram; Liang-nian Ji; Mauro Ferrari; Zong-wan Mao; Haifa Shen
Journal:  Adv Healthc Mater       Date:  2014-04-01       Impact factor: 9.933

Review 5.  Off to the organelles - killing cancer cells with targeted gold nanoparticles.

Authors:  Mohamed Kodiha; Yi Meng Wang; Eliza Hutter; Dusica Maysinger; Ursula Stochaj
Journal:  Theranostics       Date:  2015-01-21       Impact factor: 11.556

6.  Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles.

Authors:  Yichun Qian; Mantang Qiu; Qingquan Wu; Yanyan Tian; Yu Zhang; Ning Gu; Suyi Li; Lin Xu; Rong Yin
Journal:  Sci Rep       Date:  2014-12-15       Impact factor: 4.379

Review 7.  Phytochemicals and Biogenic Metallic Nanoparticles as Anticancer Agents.

Authors:  Pasupuleti Visweswara Rao; Devi Nallappan; Kondeti Madhavi; Shafiqur Rahman; Lim Jun Wei; Siew Hua Gan
Journal:  Oxid Med Cell Longev       Date:  2016-02-23       Impact factor: 6.543

8.  Could nanoparticle corona characterization help for biological consequence prediction?

Authors:  Emilie Brun; Cécile Sicard-Roselli
Journal:  Cancer Nanotechnol       Date:  2014-10-01

9.  Novel Synthesis of Kanamycin Conjugated Gold Nanoparticles with Potent Antibacterial Activity.

Authors:  Jason N Payne; Hitesh K Waghwani; Michael G Connor; William Hamilton; Sarah Tockstein; Harsh Moolani; Fenil Chavda; Vivek Badwaik; Matthew B Lawrenz; Rajalingam Dakshinamurthy
Journal:  Front Microbiol       Date:  2016-05-02       Impact factor: 5.640

Review 10.  Gene Therapies for Cancer: Strategies, Challenges and Successes.

Authors:  Swadesh K Das; Mitchell E Menezes; Shilpa Bhatia; Xiang-Yang Wang; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.